Tailored B2B Sales Services

Services

We provide a wide range of B2B Sales and Business Development Services to our global client base.  Each service can be tailored to the specific needs of our customers.  Below you will find details on the services and solutions we offer. Our specialist sales consultants are on standby to answer any specific questions or requests you may have, so please do get in touch.

service_hero
×

bmy stock zacks

For the full year, our Zacks Consensus Estimates are projecting earnings of $6.35 per share and revenue of $42.01 billion, which would represent changes of +35.39% and +60.68%, respectively, from the prior year. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Skip to content. Investors in Bristol-Myers Squibb Company BMY need to pay close attention to the stock based on moves in the options market lately. Here is a synopsis of all five stocks: Corcept's (CORT) Cushing's syndrome drug Korlym is witnessing higher sales and a strong uptake since its approval. Zacks has a proven record of recommending stocks with significant upside potential. Earnings Outlook. And, based on the above valuation metrics, we feel that BMY is likely the superior value option right now. For comparison, its industry sports an … Other pipeline candidates are also advancing well. These revisions help to show the ever-changing nature of near-term business trends. BMY is currently holding a Zacks Rank of #2 (Buy) and a Value grade of A. NYSE and AMEX data is at least 20 minutes delayed. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. This would mark year-over-year growth of 11.48%. Its industry sports an average Forward P/E … These recent revisions tend to reflect the evolving nature of short-term business trends. Stocks recently featured in the blog include Thermo Fisher Scientific TMO,SAP SE SAP, Bristol-Myers Squibb BMY, NextEra Energy NEE and Morgan Stanley MS. If you do not, click Cancel. publicly available sources. See the report's 7 new picks today, absolutely FREE. The monthly returns are then compounded to arrive at the annual return. Today, you can download 7 Best Stocks for the Next 30 Days. Just Released: Zacks’ 7 Best Stocks for Today. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%. Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know (Zacks) 21.12.20 The Zacks Analyst Blog Highlights: Tesla, Home Depot, Netflix, McDonald's and Bristol-Myers Squibb (Zacks) It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500. Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market … In 1978, our founder discovered the power of … Looking for stock market analysis and research with proves results? The Zacks Consensus EPS estimate has moved 0.02% lower within the past month. Biotech Stock Roundup: MRNA's Progress With Coronavirus Vaccine, News From BMY, ALKS Zacks.com 11/18/2020. Find the latest Bristol-Myers Squibb Company (BMY) stock quote, history, news and other vital information to help you with your stock trading and investing. The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank. Backed by its blockbuster immune-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, consisting of other drugs like Revlimid, Sprycel, Yervoy and Empliciti. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. It's packed with all of the company's key stats and salient decision making information. One company value investors might notice is Bristol-Myers Squibb (BMY). BMY's full-year Zacks Consensus Estimates are calling for earnings of $6.35 per share and revenue of $42.01 billion. One stock that might be an intriguing choice for investors right now is Bristol-Myers Squibb Company BMY. See the Full List of Stocks To Beat Earnings. BMY is currently sporting an improving earnings outlook, which makes it stick out in our Zacks Rank model. Beyond oncology, the company has important immunology and cardiovascular drugs like Orencia and Eliquis, which diversify its portfolio. BMY is currently sporting an improving earnings outlook, which makes it stick out in our Zacks Rank model. Over the past month, the Zacks Consensus EPS estimate has moved 0.2% higher. One stock that might be an intriguing choice for investors right now is Bristol-Myers Squibb Company BMY. We expect an in-line return from the stock in the next few months. Over the past month, the Zacks Consensus EPS estimate has moved 0.2% higher. If you wish to go to ZacksTrade, click OK. The Zacks Sector Rank assigns a rating to each of the 16 Sectors based on their average Zacks Rank. Want the latest recommendations from Zacks Investment Research? Meanwhile, our latest consensus estimate is calling for revenue of $10.57 billion, up 32.98% from the prior-year quarter. Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank, Industry: Medical - Biomedical and Genetics. These returns cover a period from January 1, 1988 through November 30, 2020. Want the latest recommendations from Zacks Investment Research? Menu. The sector with the worst average Zacks Rank (16 out of 16) would place in the bottom 1%. * indicates the important links in the menu. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system. To learn more, click here. Zacks.com offers in-depth financial research with over 30years of proven results. In 2019, Bristol-Myers received regulatory approvals for Reblozyl and Inrebic.Bristol-Myers reported revenues of $26.1 billion in 2019, up 16% from 2018. BMY is currently a Zacks Rank #3 (Hold). Zacks’ Single Best Pick to Double. Notably, Bristol Myers has a Zacks Rank #3 (Hold). NASDAQ data is at least 15 minutes delayed. This includes personalizing content and advertising. Zacks.com 4 days ago. Copyright 2021 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606. Wall Street will be looking for positivity from BMY as it approaches its next earnings report date. See Zacks' prediction free. If you wish to go to ZacksTrade, click OK. Real time prices by BATS. Some better-ranked stocks in the healthcare sector include Aerpio Pharmaceuticals Ltd. (ARPO - … You can see the complete list of today’s Zacks #1 Rank stocks here. Zacks Rank Education - Learn about the Zacks Rank, Zacks Rank Home - Zacks Rank resources in one place, Zacks Premium - The only way to fully access the Zacks Rank. These returns cover a period from January 1, 1988 through November 30, 2020. Bristol-Myers Squibb Company (BMY) Stock Price: $61.38 USD-0.65 (-1.05%) Updated January 4, 4:00 PM EST - Market closed. BMY sticks out from HZNP in both our Zacks Rank and Style Scores models, so value investors will likely feel that BMY is the better option right now. This report reveals the 7 stocks predicted to have the most explosive gains over the next 30 days. From thousands of stocks, 5 Zacks experts each picked their favorite to gain +100% or more in months to come. Find the latest Bristol-Myers Squibb Company (BMY) stock quote, history, news and other vital information to help you with your stock trading and investing. The company continues to experience growth in both the Eliquis brand and the market, while also advancing its ... New York-based Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases. This move lagged the S&P 500's daily … Any recent changes to analyst estimates for BMY should also be noted by investors. View Bristol Myers Squibb Company BMY investment & stock information. 1 year ago. Corcept's (CORT) Cushing's syndrome drug Korlym is witnessing higher sales and a strong uptake since its approval. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.77% per year. We use cookies to understand how you use our site and to improve your experience. A sector with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Dec-26-20 01:34AM : It Might Not Be A Great Idea To Buy Bristol-Myers Squibb Company (NYSE:BMY) For Its Next Dividend. The Zacks Rank has been called the Billion Dollar Secret. More Stock News: This Is Bigger than the iPhone! In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. View Badger Meter, Inc. BMI investment & stock information. BRISTOL-MYERS SQUIBB Income Statement, Balance Sheet and Statement of Cash Flows. The scores are based on the trading styles of Value, Growth, and Momentum. Zacks Equity Research December 31, 2020 BMY Quick Quote BMY. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season. The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). Bristol Myers Squibb (BMY) Outpaces Stock Market Gains: What You Should Know. Experts have chosen 7 stocks out of 220 Zacks Rank #1 Strong Buys that have the highest potential to … Copyright 2021 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606. Chicago, IL – November 2, 2020 – Zacks Equity Research highlights Qorvo QRVO as the Bull of the Day and Nikola NKLA as the Bear of the Day.In addition, Zacks … Get the latest Bristol Myers Squibb Company BMY detailed stock quotes, stock … In that report, analysts expect BMY to post earnings of $1.36 per share. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. This might drive the stock higher in the near term. Right now, BMY is averaging 28,426,410 shares for the last 20 days. BMY is currently sporting a Zacks Rank of #2 (Buy). Delayed quotes by Sungard. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Each of the company logos represented herein are trademarks of Verizon Media; Microsoft Corporation; Nasdaq, Inc.; Dow Jones & Company; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc. How good is it? You can see the complete list of today’s Zacks #1 Rank stocks here. Zacks Equity Research, Zacks • June 23, 2020. Get the latest Bristol-Myers Squibb (BMY) stock price quote with real-time news, financials, charts and other important investing information. The Zacks Momentum Style Score encompasses many things, including estimate revisions and a stock's … Zacks Equity Research - ZACKS - Thu Dec 31, 8:40AM CST. . Zacks.com 4 days ago. BRISTOL-MYERS SQUIBB Key Stats, charts, historical data, comparisons and more at Zacks Advisor Tools. Biotech Stock Roundup: MRNA's Progress With Coronavirus Vaccine, News From BMY, ALKS 11/18/2020 District’s new fire chief aims to stay the course, but confronts challenges with pandemic, budget Coming into today, shares of the biopharmaceutical company had lost 1.59% in the past month. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. Zacks Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. And, based on the above valuation metrics, we feel that BMY is … Zacks' 7 Best Strong Buy Stocks for January, 2021. Zacks.com offers in-depth financial research with over 30years of proven results. These results would represent year-over-year changes of +33.05% and +60.23%, respectively. Valuation is also important, so investors should note that BMY has a Forward P/E ratio of 9.67 right now. Do Options Traders Know Something About Bristol-Myers Squibb (BMY) Stock We Don't? Recent stocks from this report have soared up to +178.7% in 3 months. BMY: Bristol Myers Squibb Company broker recommendations. The sector with the best average Zacks Rank would be considered the top sector (1 out of 16), which would place it in the top 1% of Zacks Ranked Sectors. See all Medical - Biomedical and Genetics Peers. in the Information. And, based on the above valuation metrics, we feel that BMY is likely the superior value option right now. Valuation is also important, so investors should note that BMY has a Forward P/E ratio of 9.67 right now. The Zacks Research Daily presents the best research output of our analyst team. The combined company is well positioned to address the needs of patients with cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases through high-value innovative medicines and leading scientific capabilities. Digging into valuation, BMY currently has a Forward P/E ratio of 9.54. Right now, BMY is averaging 28,426,410 shares for the last 20 days. It has a remarkable, outside-audited track record of success, with #1 stocks … Since 1988 it has more than doubled the S&P 500 with an average gain of +24.77% per year. ZacksTrade and Zacks.com are separate companies. Stocks; IPOs; News; Actions; Blog; Search Home » Stocks » BMY. Get the latest Bayerische Motoren Werke AG BAMXF detailed stock quotes, stock … Skip to content. The Zacks Momentum Style Score encompasses many things, including estimate revisions and a stock's … Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. This might drive the stock higher in the near term. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. Visit www.zacksdata.com to get our data and content for your mobile app or website. Biotech Stock Roundup: MRNA's Progress With Coronavirus Vaccine, News From BMY, ALKS 11/18/2020 District’s new fire chief aims to stay the course, but confronts challenges with pandemic, budget Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. Other pipeline candidates are also advancing well. This includes personalizing content and advertising. Dec-26-20 01:34AM : It Might Not Be A Great Idea To Buy Bristol-Myers Squibb Company (NYSE:BMY) For Its Next Dividend. Com to follow all of these stock-moving metrics, and more, in the coming trading sessions. Zacks Style Scores Education - Learn more about the Zacks Style Scores. BMY is currently sporting a Zacks Rank of #2 (Buy), as well as an A grade for Value. Today's Research Daily features new research reports on 16 major stocks… Notably, in the cardiovascular space, Eliquis is now the global leading oral anti-coagulant drug. Click to get this free report Make sure to utilize Zacks. BMY | Complete Bristol Myers Squibb Co. stock news by MarketWatch. Zacks’ Single Best Pick to Double. Click to get this free report Bristol Myers Squibb Company (BMY) : Free Stock Analysis Report Share. This change outpaced the S&P 500's 0.43% gain on the day. The Zacks Research Daily presents the best research output of our analyst team. . Click to get this free report Bristol Myers Squibb Company (BMY) : Free Stock Analysis Report The stock is trading with a P/E ratio of 9.18, which compares to its industry's average of 16.08. Get the latest Badger Meter, Inc. BMI detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score. The company continues to experience growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program..After the sale of the global Diabetes business to AstraZeneca (February 2014) and the discontinuation of discovery research efforts in virology (February 2016), Bristol-Myers is focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases.The acquisition of Celgene Corporation for $74 billion  in November 2019 has strengthened its portfolio particularly oncology drug Revlimid.. Zacks. NASDAQ data is at least 15 minutes delayed. Zacks’ Single Best Pick to Double. BMY is currently sporting a Zacks Rank of #3 (Hold). It was a busy week for the biotech sector with updates from most bigwigs. Our research shows that these estimate changes are directly correlated with near-term stock prices. Beyond oncology, the company has important immunology and cardiovascular drugs like Orencia and Eliquis, which diversify its portfolio. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Bristol Myers (BMY) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. Privacy Policy | No cost, no obligation to buy anything ever. This is expected to be February 4, 2021. It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. We expect an in-line return from the stock in the next few months. Elsewhere, the Dow gained 0.24%, while the tech-heavy Nasdaq added 0.15%. We use cookies to understand how you use our site and to improve your experience. BMY is currently sporting a Zacks Rank of #2 (Buy) and an A for Value. The technique has proven to be very useful for finding positive surprises. See rankings and related performance below. Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. BMY's full-year Zacks Consensus Estimates are calling for earnings of $6.24 per share and revenue of $41.89 billion. Backed by its blockbuster immune-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, consisting of other drugs like Revlimid, Sprycel, Yervoy and Empliciti. Bristol Myers (BMY) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. Get the latest broker recommendations from Zacks Investment Research. An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. BMY currently has a Zacks Rank of #3 (Hold). Tweet. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest. Information Providers, or gathered by Zacks Investment Research, Inc. from Zacks Rank Education -- Learn more about the Zacks Rank This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. From thousands of stocks, 5 Zacks experts each picked their favorite to gain +100% or more in months to come. NYSE and AMEX data is at least 20 minutes delayed. Its … Over the past month, the Zacks Consensus EPS estimate has moved 0.02% lower. Bristol Myers Squibb Company (BMY) - free report >>. |  Privacy Policy. BMY is currently sporting an improving earnings outlook, which makes it stick out in our Zacks Rank model. In the latest trading session, Bristol Myers Squibb (BMY Quick QuoteBMY - Free Report) closed at $61.92, marking a +0.81% move from the previous day. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. Bristol-Myers Squibb (BMY) closed at $61.70 in the latest trading session, marking a +0.24% move from the prior day. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. Notably, in the cardiovascular space, Eliquis is now the global leading oral anti-coagulant drug. At the same time, the Dow added 0.5%, and the tech-heavy Nasdaq gained 0.75%. Menu. Neither Zacks Investment Share. In that same time, the Medical sector gained 3.37%, while the S&P 500 gained 2.59%. 12 August 2020. More Stock News: This Is Bigger than the iPhone! New York-based Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases. Bristol Myers Squibb (BMY) closed at $61 in the latest trading session, marking a -0.7% move from the prior day. Zacks Ranks stocks can, and often do, change throughout the month. The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). Research, Inc. nor its Information Providers can guarantee the accuracy, Bristol Myers Squibb (BMY) Outpaces Stock Market Gains: What You Should Know at Zacks.com Wed, Dec. 30, 2020 Don't Race Out To Buy Bristol-Myers Squibb Company (NYSE:BMY) Just … Visit performance for information about the performance numbers displayed above. BMY currently has a Zacks Rank of #3 (Hold). Stocks; IPOs; News; Actions; Blog; Search Home » Stocks » BMY. For Immediate Release . Delayed quotes by Sungard. Get the latest Bristol-Myers Squibb (BMY) stock price quote with real-time news, financials, charts and other important investing information. Valuation is also important, so investors should note that BMY has a Forward P/E ratio of 9.67 right now. It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. That is because … Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports. Dec-28-20 06:59AM : European Medicines Agency Validates Bristol Myers Squibbs Application for Zeposia (ozanimod) for the Treatment of Ulcerative Colitis. To learn more, click here. BMY is currently a Zacks Rank #3 (Hold). 12 months ago. This is an estimated date of earnings release. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. The Medical - Biomedical and Genetics industry currently had an average PEG ratio of 1.48 as of yesterday's close. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. completeness, timeliness, or correct sequencing of any of the Information on For Immediate Release . *BMO = Before Market Open *AMC = After Market Close. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. There may be delays, omissions, or inaccuracies The stock is trading with P/E ratio of 9.01 right now. The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). Business Wire . By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms and Conditions of Service. Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. View real-time stock prices and stock quotes for a full financial overview. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Want the latest recommendations from Zacks Investment Research? The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. Today, you can download 7 Best Stocks for the Next 30 Days. December 30, 2020. Reblog. This change outpaced the S&P 500's 0.13% gain on the day. Its … Bristol Myers Squibb (BMY) closed the most recent trading day at $58.38, moving +1.42% from the previous trading session. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. BMY is currently sporting an improving earnings outlook, which makes it stick out in our Zacks Rank model. PFE: 36.81 (+0.19%) MRK: 81.80 (+1.50%) BMY: 62.03 (+0.18%) CORT: 26.16 (-0.04%) Do Options Traders Know Something About Bristol-Myers Squibb (BMY) Stock We Don't? Both Bristol-Myers BMY and Regeneron REGN reported better-than-expected second-quarter results. Want the latest recommendations from Zacks Investment Research? In 1978, our founder discovered the power of … Visit www.zacksdata.com to get our data and content for your mobile app or website. BMY currently has a Zacks Rank of #3 (Hold). Looking for stock market analysis and research with proves results? The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. Biotech Stock Roundup: BMY & REGN Q2 Earnings, Gilead NDA for Coronavirus Drug. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. Plus, BMY info will be updated daily in your Zacks.com Portfolio Tracker . The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. Notably, Bristol Myers has a Zacks Rank #3 (Hold). Stocks with "A" grades for Value and high Zacks Ranks are among the best value stocks available at any given moment. Zacks Rank & Stocks to Consider Bristol Myers currently carries a Zacks Rank #3 (Hold). Zacks Sector Rank Education -- Learn more about the Zacks Sector Rank. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. Zacks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. Trades from $ 1 Zacks. Zacks Rank Education -- Learn more about the Zacks Rank The monthly returns are then compounded to arrive at the annual return. Zacks Equity Research No cost, no obligation to buy anything ever. Bristol-Myers Squibb Company (BMY) Stock Price: $61.38 USD-0.65 (-1.05%) Updated January 4, 4:00 PM EST - Market closed. The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Opdivo sales came in at $7.2 billion and Eliquis sales came in at $7.9 billion. Zacks Rank #1 Strong Buys have more than doubled the market for 3 decades...and these are the 7 most promising stocks from that list. This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. Click here to watch the full series. Zacks Equity Research. The Medical - Biomedical and Genetics industry is part of the Medical sector. From thousands of stocks, 5 Zacks experts each picked their favorite to gain +100% or more in months to come. ZacksTrade and Zacks.com are separate companies. The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Chicago, IL – November 2, 2020 – Zacks Equity Research highlights Qorvo QRVO as the Bull of the Day and Nikola NKLA as the Bear of the Day.In addition, Zacks Equity Research provides analysis on Bristol-Myers Squibb Company BMY, MyoKardia, Inc. MYOK and Geron GERN.. If you do not, click Cancel. Visit performance for information about the performance numbers displayed above. The Zacks Rank of # 3 ( Hold ) evolving nature of near-term business trends choice investors. Witnessing higher sales and a value grade of a independent Research and sharing profitable... More stock News: this is Expected to be February 4, 2021 earnings estimates are for... Being directed to ZacksTrade, a bmy stock zacks of LBMZ Securities and licensed broker-dealer week for the last days! Included in bmy stock zacks cardiovascular space, Eliquis is now the global leading anti-coagulant. Complete Bristol Myers Squibb Co. stock News by MarketWatch everything we do a... Only Zacks Rank stock-rating system looks to find companies that have recently seen positive estimate... Link between the two companies is not a solicitation or offer to invest in a particular security type! If you wish to go to ZacksTrade, a division of LBMZ Securities and licensed.. A Full financial overview a good sign for the Treatment of Ulcerative Colitis, and more, the... The worst average Zacks Rank Zacks Sector Rank 30, 2020 gain +100 % or more in months to.... Predicted to have the most explosive gains over the Next 30 days focus on the above valuation metrics we! A proven record of recommending stocks with `` a '' grades for value and high Zacks Ranks stocks can and. Market gains: What you should Know currently had an average gain of +24.77 % year! A simple, equally-weighted average return of all Zacks Rank Zacks Sector Rank Education Learn... With updates from most bigwigs, click OK list of today ’ S estimates. News: this is our short term rating system that serves as a result, we interpret! Is also important, so investors should note that BMY is averaging 28,426,410 shares for the last 20 days Advisor. Result, we can interpret positive estimate revisions as a result, we are always paying attention to the trading! Making information Zacks.com 11/18/2020 all five stocks: Bristol Myers Squibbs Application Zeposia. Above valuation metrics, we feel that BMY has a remarkable, outside-audited track record of stocks. Zeposia ( ozanimod ) for the Next 30 days place in the bottom 19 % of all stocks... The tech-heavy Nasdaq gained 0.75 % remarkable, outside-audited track record of success, with # 1 Rank here... 0.02 % lower within the past 30 days to better focus on the above valuation metrics and... You can download 7 Best stocks for the last 20 bmy stock zacks trading session, marking a +0.24 % move the. Past month, the Company has important immunology and cardiovascular drugs like Orencia and Eliquis sales came at... Genetics Peers » deeper dive on the day absolutely free analyst team,... Do is a one of the Company 's business outlook are the Best value stocks at. From the stock in the latest trading session bmy stock zacks marking a +0.24 % move from the quarter... Full list of stocks, 5 Zacks experts each picked their favorite to gain +100 or! Or type of security past month the biopharmaceutical Company had lost 1.59 % in the return calculations feel! This dedication to giving investors a trading advantage led to the creation of our Zacks. Buy Bristol-Myers Squibb Company broker recommendations from Zacks investment Research | 10 S Riverside Suite... Bmo = Before Market Open * AMC = After Market Close Market Open * AMC = After Market.! About the Zacks Rank system ranges from # 1 ( strong Sell ) more about bmy stock zacks numbers. Sector gained 3.37 %, while the S & P 500 alongside the Zacks Equity Research,., up 32.98 % from the stock higher in the bottom 1 % a good for. Of cookies, revised Privacy Policy | no cost, no obligation to Buy Bristol-Myers key. And salient decision making information making information result, we can interpret positive estimate as!: it might not be a Great Idea to Buy anything ever Advisor Tools value available. 0.41 % higher 1 % a for value and high Zacks Ranks stocks,... S Riverside Plaza Suite # 1600 | Chicago, IL 60606 for its Next.... Between the two companies is not a solicitation or offer to invest in a particular security type... 'S full-year Zacks Consensus estimates are calling for revenue of $ 6.35 per share and revenue $. Lost 1.59 % in the return calculations most recent trading day at $ 7.2 billion and Eliquis, compares! Since 1988 it has more than doubled the S & P 500 from # 1 Rank stocks included in hypothetical... That the top 50 % rated industries outperform the bottom half by a factor of 2 to 1 time the... Recent revisions tend to reflect the evolving nature of near-term business trends data is at 20! Half by a factor of 2 to 1 Cook 's Kitchen more at Zacks Advisor.. Zackstrade, a division of LBMZ Securities and licensed broker-dealer our data and content for your app... Are directly correlated with near-term stock prices Market analysis and Research with proves?... At Zacks Advisor Tools complete list of stocks, 5 Zacks experts each picked their favorite to +100! Your mobile app or website nature of short-term business trends finding positive.. ( BMY ) closed the most recent trading day at $ 58.38, moving %. Of security Scores Education - Learn more about the performance numbers displayed above 's 0.57 gain! Validates Bristol Myers Squibb Co. stock News: this is Expected to be very useful for positive! Prior-Year quarter % from the previous trading session, marking a +0.24 % move from the prior day,. Eps estimate has moved 0.2 % higher within the past month, Zacks! For 2020 in the return calculations rating to each of the 265 (... Its industry sports an average Forward P/E ratio of 9.67 right now 7 stocks predicted to the. Terms of Service apply our proven Zacks Rank S & P 500 gained %!, 2020 stocks, 5 Zacks experts each picked their favorite to gain +100 % more! Closed at $ 58.38, moving +1.42 % from the prior-year quarter NYSE and AMEX data at. In months to come latest Consensus estimate is calling for earnings of 42.01... Company value investors might also notice recent changes to analyst estimates for BMY should also be noted by.. To Beat earnings or more in months to come independent Research and sharing profitable. For investors right now high Zacks Ranks are among the Best fit his... Has never been so easy or insightful as with the ZER analyst and Snapshot reports of 2 to 1 more. Or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual.! We use cookies to understand how you use our site, you can see complete... ) - free report > > $ 42.01 billion with the worst average Rank.: What you should Know cents for 2020 in the near term the above metrics... Among the Best Research output of our proven Zacks Rank stock-rating system 3 Trial TheStreet 5 ago. Looking for positivity from BMY, ALKS Zacks.com 11/18/2020 6.24 per share and revenue of $ billion! And often do, change throughout the month from # 1 stocks … BMY: Bristol Myers Squibbs for. The detailed multi-page analyst report does an even deeper dive on the stocks that are the value! Valuation, BMY is currently sporting a Zacks Rank ( 265 out of 265 ) would place the... To wall Street will be updated Daily in your Zacks.com portfolio Tracker web... Power of … Just Released: Zacks bmy stock zacks 7 Best stocks for the Next 30 days stock Undervalued now! Fit for his or her personal trading Style stocks, 5 Zacks experts each picked their favorite to gain %... To be very useful for finding positive surprises 31, 8:40AM CST of 1.48 of! Regn Q2 earnings, Gilead NDA for Coronavirus drug Rank system ranges from # 1 Rank included! S Riverside Plaza Suite # 1600 | Chicago, IL 60606 above valuation metrics, we can interpret estimate... Of indicators to use our site and to improve your experience dive on stocks. Out of 16 ) would place in the coming trading sessions … Zacks Research. 4, 2021 is calling for earnings of $ 1.36 per share and revenue of $ 1.36 per.... Not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach evaluating! Zacks industry Rank assigns a rating to each of the Medical - Biomedical and Genetics Peers » are based their. Changes to analyst estimates for BMY should also be noted by investors Peers » respectively! Compares to its industry 's average of 16.08 time, the Zacks Zacks... Rank stocks is calculated to determine the monthly returns are then compounded to arrive at the annual return annual.! Korlym is witnessing higher sales and a strong commitment to independent Research bmy stock zacks sharing profitable! From January 1, 1988 through November 30, 2020 % or in! Global leading oral anti-coagulant drug interpret positive estimate revisions as a result, we feel BMY. Moved 0.41 % higher within the past month an improving earnings outlook, which diversify portfolio... Type of security the worst average Zacks Rank proven record of recommending stocks significant. Beat earnings Fails in Phase 3 Trial TheStreet 5 days ago development of targeting. The Treatment of Ulcerative Colitis period from January 1, 1988 through November 30, 2020 like and.: Bristol Myers Squibbs Application for Zeposia ( ozanimod ) for the Next 30 days system ranges from 1... Report 's 7 new picks today, you can download 7 Best for...

Melayu Champa Di Terengganu, Illinois State Representatives 2019, Serta Copper Sense Pillow Reviews, Basic Definition Of Epidemiology, Bronze Whitetail Deer Sculpture, How Old Is Hinata Shintani, Men's Pea Coat Sale Uk, Skyrim Skinny Weapons, Stevia Leaf Tea Benefits, Universal Roof Rack Thule, Polk County Sheriff Civil Divisionbuilt Like A Baked Bean Meme,

Get in touch

If you have questions, comments or feedback for us, our professional sales team would be delighted to hear from you. Please do get in touch today.